TEMPEST THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.69 USD | +4.24% |
|
+4.24% | -16.14% |
Chart calendar Tempest Therapeutics, Inc.
1c524c16b1f5a.bLz9aaFy4PRw-l6YboHW2XPdpDWjshgcBwxdt2oxvqo.LeTPDcIIor4drg_bJNiQrz6t10HU0CFvRFsK2h5JxOgt5bU9zhe2sBidKQ~185e75528e82b4ec1b152d94fc40140e
Upcoming events on Tempest Therapeutics, Inc.
Past events on Tempest Therapeutics, Inc.
| 2024-04-08 16:30 | American Association for Cancer Research Meeting - Abstract Number: 3045 |
| 2024-03-19 16:25 | Q4 2023 Earnings Release |
| 2024-03-04 09:10 | TD Cowen Health Care Conference |
| 2023-11-28 15:00 | Piper Sandler Healthcare Conference |
| 2023-11-08 17:17 | Q3 2023 Earnings Release |
| 2023-10-11 08:30 | TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call |
| 2023-09-11 07:00 | H.C. Wainwright Global Investment Conference |
| 2023-08-10 16:13 | Q2 2023 Earnings Release |
| 2023-06-15 16:00 | Annual General Meeting |
| 2023-06-07 14:00 | Jefferies Global Healthcare Conference |
| 2023-06-03 08:00 | American Society of Clinical Oncology Conference - Abstract Number : 3107 |
| 2023-05-10 16:15 | Q1 2023 Earnings Release |
| 2023-04-28 08:30 | TPST-1120 Phase 1b/2 Study Results Call |
| 2023-04-17 09:00 | American Association for Cancer Research Meeting - Abstract No 2130 |
| 2023-04-17 09:00 | American Association for Cancer Research Meeting - Abstract No 1636 |
| 2023-03-22 17:26 | Q4 2022 Earnings Release |
| 2023-03-16 | Society for Immunotherapy of Cancer Spring Scientific Meeting - Abstract Number:78 |
| 2022-11-29 11:30 | Piper Sandler Healthcare Conference |
| 2022-11-10 09:00 | Society for Immunotherapy of Cancer Meeting - Abstract No 1471 |
| 2022-11-10 09:00 | Society for Immunotherapy of Cancer Meeting - Abstract No 1331 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -27,0 -27,8 2.93% | -34,6 -36,0 3.78% | -28,8 -29,6 2.78% | -35,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -27,0 -27,8 2.99% | -34,6 -35,3 1.8% | -29,2 -28,8 -1.28% | -33,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -35,7 -36,0 0.84% | -29,5 -29,5 -0.14% | -33,2 |
|
Net income Million USD | Released Forecast Spread | -19,2 | 0,00 0,00 - | -35,7 -36,0 0.84% | -29,5 -29,5 -0.14% | -33,2 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -3,09 -3,52 12.22% | -1,91 -1,94 1.29% | -1,41 |
| Announcement Date | 13/04/21 | 29/03/22 | 22/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -7,34 -8,20 10.51% | -8,66 -8,40 -3.12% | -8,77 -9,40 6.69% | -8,93 -10,3 13.26% | -7,58 -9,10 16.69% | -7,39 -8,70 15.09% | -6,50 -8,10 19.7% | -7,43 -8,00 7.14% | -7,80 | -8,30 | -8,70 | -10,9 | ||
|
EBIT Million USD | Released Forecast Spread | -7,34 -8,18 10.34% | -8,16 -7,44 -9.72% | -8,77 -8,60 -1.98% | -8,77 -9,12 3.78% | -8,93 -9,33 4.2% | -7,58 -8,98 15.53% | -7,47 -7,82 4.52% | -6,59 -7,71 14.47% | -7,51 -6,92 -8.63% | -7,61 | -7,98 | -8,11 | -9,00 | -9,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,10 -9,41 3.22% | -7,64 -9,14 16.44% | -7,58 -7,95 4.69% | -6,79 -7,84 13.39% | -7,49 -7,32 -2.35% | -7,61 | -8,07 | -8,17 | -9,20 | -9,90 | ||||
|
Net income Million USD | Released Forecast Spread | -9,10 -9,41 3.22% | -7,64 -9,14 16.44% | -7,58 -7,95 4.69% | -6,79 -7,84 13.39% | -7,49 -7,32 -2.35% | -7,61 | -8,07 | -8,17 | -9,20 | -9,90 | ||||
|
EPS USD | Released Forecast Spread | -0,63 -0,89 29.21% | -0,55 -0,62 11.29% | -0,54 -0,48 -13.29% | -0,48 -0,57 15.29% | -0,34 -0,39 12.07% | -0,37 | -0,36 | -0,32 | -0,36 | -0,49 | ||||
| Announcement Date | 29/03/22 | 13/05/22 | 15/08/22 | 08/11/22 | 22/03/23 | 10/05/23 | 10/08/23 | 08/11/23 | 19/03/24 | - | - | - | - | - |
More events
Past sector events for Tempest Therapeutics, Inc.
| 2024-05-02 16:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TPST Stock
- Calendar Tempest Therapeutics, Inc.
